SAMSUNG PHARM. Co., LTD.
KSE 001360.KS
SAMSUNG PHARM. Co., LTD. Shares (Diluted, Weighted) for the year ending December 31, 2023: 74,325,689
-
SAMSUNG PHARM. Co., LTD. Shares (Diluted, Weighted) for the year ending December 31, 2022 was 74,393,049, a 1.16% change year over year.
-
SAMSUNG PHARM. Co., LTD. Shares (Diluted, Weighted) for the year ending December 31, 2021 was 73,539,255, a 8.63% change year over year.
-
SAMSUNG PHARM. Co., LTD. Shares (Diluted, Weighted) for the year ending December 31, 2020 was 67,699,186, a 4.29% change year over year.
-
SAMSUNG PHARM. Co., LTD. Shares (Diluted, Weighted) for the year ending December 31, 2019 was 64,915,497, a 26.69% change year over year.
| Date | Shares (Diluted, Weighted) | Revenue | Cost of Revenue | Gross Profit |
|---|
| CEO | Mr. Won-Kyu Kim |
| IPO Date | Jan. 4, 2000 |
| Location | South Korea |
| Headquarters | 35 Jeyakgongdan 2-gil |
| Employees | 240 |
| Sector | Health Care |
| Industries | |
SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, mixed vitamins, antibiotics, and others. The company also provides medicines for digestive system, medicines for liver disorder, medicines for circulation system, cold medicines, nutritional supplements, health tonics, and others, as well as vitamins and energy drinks, and functional foods. The company was founded in 1929 and is based in Hwaseong-si, South Korea.
Past 5 years
USD 10.03
USD 29.43
USD 244.50
USD 7.51
StockViz Staff
January 15, 2025
Any question? Send us an email